Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Schedules First-Quarter 2005 Earnings Release and Conference Call

WILMINGTON, Mass., April 6 /PRNewswire-FirstCall/ -- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2005 financial results on Tuesday, May 3, 2005, after the market closes. A conference call has been scheduled to discuss the results on Wednesday, May 4, 2005, at 8:30 a.m. E.T.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at http://ir.criver.com. A replay will be accessible through the website approximately two hours following the conference call and will remain available until Wednesday, May 11, 2005.

Charles River Laboratories, based in Wilmington, Massachusetts, is a global provider of solutions that advance the drug discovery and development process. Our leading-edge products and services are designed to enable our clients to bring drugs to market faster and more efficiently. Backed by our rigorous, best-in-class procedures and our proven data collection, analysis and reporting capabilities, our products and services are organized into three categories spanning every step of the drug development pipeline: Research Models and Services, Preclinical Services, and Clinical Services. Charles River's customer base includes all of the major pharmaceutical companies, biotechnology companies, government agencies and many leading hospitals and academic institutions. Charles River's 8,000 employees serve clients in more than 50 countries. For more information on Charles River, visit our website at http://www.criver.com.

Investor Relations Contact:
Susan E. Hardy
Director, Investor Relations
(978)658-6000 Ext.1616

SOURCE Charles River Laboratories International, Inc.
/Web Site: http://www.criver.com /
(CRL)

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)